MoneyWorks4Me

Lupin board to consider unaudited financial results

15 Oct 2013 Evaluate

Lupin has informed that a meeting of the Board of Directors of the company will be held on October 30, 2013 to consider and take on record unaudited financial results for the quarter ended September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..